Pasithea Therapeutics 3.57M share Secondary priced at $1.40

finance.yahoo.com/news/pasithea-therapeutics-3-57m-share-153533180.html

In This Article:
The gross proceeds to the company from the offering are expected to be approximately $5M, before deducting the placement agent’s fees and other offering expenses payable by the company. The company intends to use the net proceeds from this offering for general corporate…

This story appeared on finance.yahoo.com, 2025-05-07 15:35:33.
The Entire Business World on a Single Page. Free to Use →